Evidence map›Paper›PMID 36262770›Full record

ArticleEuropean heart journal open2022

European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease.

Anna Sannino, Sarah Campbell, Julia Grapsa, Thomas Modine, Marco Barbanti, John B Chambers, Jose L Zamorano, Philippe Pibarot, Madalina Garbi, Mani Vannan and 2 more

Erratum issuedAbstract read
In one paragraph

Article in European heart journal open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Anna SanninoDepartment of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Sarah CampbellDepartment of Cardiology, Guys and St Thomas NHS Trust, London, United Kingdom.
Julia GrapsaDepartment of Cardiology, Guys and St Thomas NHS Trust, London, United Kingdom.ORCID https://orcid.org/0000-0003-4620-6234
Thomas ModineService Médico-Chirurgical, Valvulopathies-Chirurgie Cardiaque-Cardiologie Interventionelle Structurelle, Hôpital Cardiologique de Haut Lévèque, Bordeaux, France.
Marco BarbantiFerrarotto Hospital, University of Catania, Catania, Italy.
John B ChambersDepartment of Cardiology, Guys and St Thomas NHS Trust, London, United Kingdom.
Jose L ZamoranoDepartment of Cardiology, Hospital Universitario Ramón y Cajal, M-607, 9, 100, 28034 Madrid, Spain.
Philippe PibarotInstitut de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Québec, Canada.
Madalina GarbiDepartment of Cardiology, Royal Papworth Hospital, Cambridge Biomedical Campus, Cambridge, UK.
Mani VannanPiedmont Heart Institute, Atlanta, Georgia.
Gilbert HabibCardiology Department, AP-HM, La Timone Hospital, Marseille, France.
Patrizio LancellottiCardiology Department, University Hospital Centre, Centre Hospitalier Universitaire (CHU) Sart Tilman, Liège, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. Methods and results: A total of 33 questions, distributed via email to all European Society of Cardiology (ESC) affiliated countries through the newsletter of the ESC council on VHD, were answered by 689 respondents, mainly from tertiary care settings. The results of this survey showed that VHD patients are mostly managed by tertiary care centres, where multi-disciplinary heart teams are frequently a reality. Cardiac computed tomography (CT) is often used in the preprocedural planning of transcatheter interventions, particularly for sizing and deliverability assessment. Echocardiography represents the most widely used imaging modality in the diagnostic, intra-operative and follow-up phase of VHD patients. Cardiac magnetic resonance (CMR) is still largely underused, also for conditions such as mitral annular disjunction, or for the assessment of left ventricle volumes where it is considered as the gold standard, despite 3D volumes by echocardiography having proved good comparability with CMR. As for endocarditis, despite still underused, transesophageal echocardiography (TEE) represents the approach of choice for the diagnosis of native and prosthesis valve endocarditis (up to 46% of the respondents use it). In this context, positron emission tomography-CT is largely underused. Conclusion: There is widespread adoption of current recommendation on the evaluation of VHD and these are frequently used to guide patient management. Nonetheless, there are still many discrepancies across centres and countries which need to be addressed with the aim of improving patients' management and outcomes and ultimately positively impacting on healthcare resources.

Indexed as

ClinicsSurveyValvular

Identifiers

PMID36262770
PMCPMC9562836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.